as 07-25-2025 4:00pm EST
Stocks
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | BELLEVUE |
Market Cap: | 19.0M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 927.3K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.80 | EPS Growth: | N/A |
52 Week Low/High: | $0.90 - $13.40 | Next Earning Date: | 08-24-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
OSRH Breaking Stock News: Dive into OSRH Ticker-Specific Updates for Smart Investing
GOBankingRates
2 months ago
GOBankingRates
2 months ago
GOBankingRates
2 months ago
Yahoo Finance
2 months ago
The Guardian
2 months ago
Yahoo Finance Video
2 months ago
Benzinga
2 months ago
Reuters
2 months ago
The information presented on this page, "OSRH OSR Holdings Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.